Vanda Pharmaceuticals (VNDA) Tax Provisions (2010 - 2026)
Vanda Pharmaceuticals (VNDA) posted Tax Provisions of $100000.0 for Q1 2026, down 99.9% sequentially from $103.2 million in Q4 2025, and up 101.27% YoY from $49684.5 in Q1 2025.
Vanda Pharmaceuticals (VNDA) Tax Provisions (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals has reported Tax Provisions for 12 years, with the latest figure at $100000.0 in Q1 2026.
- Quarterly Tax Provisions rose 101.27% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $89.8 million (up 888.07% YoY) and the FY2025 annual result came in at $81.8 million, up 2134.99% from the prior year.
- Tax Provisions slipped to $100000.0 in Q1 2026 per VNDA's latest filing, from $103.2 million in the prior quarter.
- Over five years, Tax Provisions peaked at $103.2 million in Q4 2025 and troughed at -$7.9 million in Q1 2025.
- A 5-year average of $5.1 million and a median of -$257000.0 in 2023 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 6465.52% in 2025, down 1420.08% in 2025.
- Over 5 years, Tax Provisions stood at $2.8 million in 2022, then sank by 73.47% to $730000.0 in 2023, then slumped by 322.05% to -$1.6 million in 2024, then soared by 6465.52% to $103.2 million in 2025, then sank by 99.9% to $100000.0 in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered $100000.0, $103.2 million, and -$5.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Vanda Pharmaceuticals | 315.57 Mn | 145.54 Mn | 46.97 Mn | 129,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 129,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 103.19 Mn |
| Sep 30, 2025 | -5.80 Mn |
| Jun 30, 2025 | -7.70 Mn |
| Mar 31, 2025 | -7.87 Mn |
| Dec 31, 2024 | -1.62 Mn |
| Sep 30, 2024 | -900,000.00 |
| Jun 30, 2024 | -998,000.00 |
| Mar 31, 2024 | -518,000.00 |
| Dec 31, 2023 | 730,000.00 |
| Sep 30, 2023 | -257,000.00 |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Sep 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | -1.10 Mn |
| Dec 31, 2021 | 1.53 Mn |
| Sep 30, 2021 | 3.00 Mn |